Featured News

A recent international study co-authored by Celiac Disease Foundation grant award winner Dr. Benjamin Lebwohl aimed to assess the effectiveness of the Pfizer COVID-19 vaccine in patients with celiac disease. Results revealed that the Pfizer COVID-19 vaccine offers the same level of protection against the virus for patients with celiac disease as it does for those without the autoimmune disease.

researchers concluded that patients with celiac disease who are infected with COVID-19 are not at higher risk of hospitalization.

The Society for the Study of Celiac Disease (SSCD) has released a statement on the COVID-19 vaccination and its safety for celiac disease patients.

We have been hearing from our community about COVID-19 and celiac disease and about our work at the Celiac Disease Foundation during the pandemic. We have answered the most frequently asked questions in a short video for you. 

Celiac disease is not considered to be an immunocompromised state in children, and is not known to be a risk factor for severe disease. Social distancing, washing hands with soap and water frequently and for at least 20 seconds, and avoiding touching of eyes, nose and mouth are recommended.

Amidst the uncertainty of the future, we have made the difficult decision to cancel the Celiac Disease Foundation’s Gluten-Free EXPO scheduled for June 13 – June 14, 2020, and not reschedule this year. 

Celiac disease is associated with an increased risk of pneumococcal infection. Though pneumococcal vaccination will not prevent COVID-19, the Celiac Disease Foundation Medical Advisory Board strongly advises people with celiac disease to consider vaccination to protect against other respiratory illness.